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Structured abstract 
Background: Cardiac resynchronization therapy (CRT) is now generally delivered via 
quadripolar leads. Assessment of the effect of different vector programs from quadripolar leads 
on ventricular activation can be now done using non-invasive electrocardiographic mapping 
(ECM).   
Material and methods: In nineteen patients with quadripolar LV leads, activation maps were 
constructed. The total ventricular activation time (TVaT) and the time for the bulk of ventricular 
activation (VaT10-90) were calculated. 
Results: CRT delivered via a quadripolar lead significantly reduced TVaT and VaT10-90 by a mean 
of 16ms and 31ms, respectively, compared to baseline. There was a marked reduction in 
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ventricular activation between the most and least synchronous vectors: 28% difference in 
baseline TVaT and 37% difference in VaT10-90.  
Conclusion: Changes in the configuration of an LV quadripolar lead significantly affected 
ventricular activation timings in both ischaemic and non-ischaemic subjects. This suggests that 
programming of the optimal pacing vector may need to be individually tailored. 
 
 
 
 
Keywords 
Cardiac resynchronization therapy; Non-invasive electrocardiographic mapping; quadripolar left 
ventricular lead; Optimisation; Ventricular activation time;  
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Introduction  
 
Cardiac resynchronisation therapy (CRT) is an effective treatment for patients with heart failure 
and electrical dyssynchrony[1] and is now generally delivered via quadripolar leads that allow 
stimulation via multiple pacing vectors.[2] This may permit more basal activation of the LV, 
which may improve resynchronisation and avoid areas of scar or phrenic nerve stimulation 
(PNS), which are both associated with a reduced response to CRT.[3] Quadripolar leads improve 
morbidity and mortality and also offer economic benefits over bipolar leads.[4,5] Although 
quadripolar leads provide multiple vector options, there is no indication that a particular vector 
delivers the best result, nor if a selected vector offers better or worst effects to a specific group 
of patients. Selection and programming of the optimal vector with quadripolar leads may be 
patient specific. The presence of scar and pattern of dyssynchrony may limit effective 
myocardial stimulation that may be overcome by optimising the LV vector to improve electrical 
resynchronisation. As such there may be differences between ischemic and non-ischaemic 
patients. We have previously shown that changes in invasively measured total ventricular 
activation time (TVaT) and the time for the 10th to 90th percentiles of the myocardium to activate 
(VaT10-90) reflecting the bulk of myocardial activation predict CRT response.[6] 
Electrocardiographic mapping (ECM) is a non-invasive mapping technique that provides 
detailed patient-specific information on epicardial electrical activation enabling the 
measurement of activation times from the epicardium of the LV and right ventricle (RV) non-
invasively with different quadripolar configurations.[7,8]  
 
We hypothesised that stimulation from different vectors of a quadripolar lead would have 
different effects on left ventricular activation times, which may be important in determining the 
optimal programming. To assess this, we used ECM to investigate the associations between 
various LV-stimulation configurations with a quadripolar LV lead by measuring the respective 
total activation times of the ventricles with regard to the subject characteristics with a focus on 
the underlying aetiology. 
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Material and methods 
This was a prospective single-site study of progressive heart failure (HF) patients receiving CRT. 
The study conformed to the principles outlined in the Declaration of Helsinki on research in 
human subjects. All subjects gave their written informed consent to participate in the study 
(approved by the Research Ethics Committee, ClinicalTrials.gov Identifier: NCT01831518.). All 
subjects fulfilled criteria for CRT implantation: NYHA Class II-IV; echocardiographic Left 
Ventricular Ejection Fraction (LVEF) < 35%, QRS duration > 120 ms (independently of the QRS 
morphology) and optimal medical therapy (OMT) for heart failure. The aetiology of heart failure 
was classified as ischaemic in the presence of substantial coronary artery disease or a history of 
myocardial infarction or revascularisation, and as non-ischaemic otherwise. Intraventricular 
conduction disturbances were defined according to the AHA/ACCF/HRS Recommendations for 
the Standardization and Interpretation of the Electrocardiogram.[9] 12-lead ECGs were acquired 
with a GE Mac 5000 ECG system (General Electric-Vingmed, Milwaukee, WI) using standard 
American Heart Association (AHA)-recommended filter settings [10] at a sweep rate of 25 mm/s 
and a gain of 10 mm/mV. Echocardiography was performed using an IE33 or EPIC model 
scanner (Philips Healthcare, Best, The Netherlands).  
CRT implantation 
Implantation was performed via the cephalic and/or axillary veins with the RV lead implanted at 
the RV apex or high septum at the discretion of the implanting physician, and the right atrial lead 
placed at the right atrial appendage. All patients were implanted with a St. Jude Medical Quartet 
leadTM, which offers 10 different LV configurations through its quadripolar electrodes – this lead 
was preferentially sited in the lateral or postero-lateral vein tributary of the coronary sinus. The 
operator sought to have all four poles of the quadripolar lead within the vein to allow for 
stimulation from all the poles. If this was not possible due to technical difficulties or because of 
unacceptable pacing thresholds or PNS, an alternative location was chosen in the anterolateral, 
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posterior, or anterior locations.  Following implantation, posteroanterior and lateral chest 
radiographic images were obtained according to standard protocols. 
Electrocardiographic mapping 
Echo-guided optimisation was performed the day following implantation: AV intervals through 
the Iterative method [11] and VV intervals by assessment of the left ventricular outflow tract 
velocity time integral (LVOT VTI) [12]. Participants underwent ECM using a CardioInsight 
ECVUE system (CardioInsight Technologies Inc., Cleveland, OH) to non-invasively provide 
biventricular epicardial ventricular electrograms and construct 3D isochrone and isopotential 
activation maps.[13] ECM maps were created on a beat-by-beat basis for all the available 
quadripolar LV lead configurations in a DDD pacing mode using the optimal atrioventricular 
delay (AVD) and VV were identified through echo-guided optimisation. If the patient was in 
atrial fibrillation VVI pacing mode was used with the optimal VV identified through echo-guided 
optimisation. All available quadripolar LV lead configurations/vectors were tested. Quadripolar 
lead configurations in which capture was not possible over 5 volts at 1.2ms were excluded, as 
were configurations that provoked diaphragmatic stimulation. After the acquisition of vest 
electrograms under each configuration, the participants, with the vest still in position, 
underwent a thoracic computed tomographic (CT) scan to determine the precise anatomic 
relation between the cardiac geometry and the torso electrodes, which was used to reconstruct 
1500 unipolar electrograms on the epicardial surface of the heart. Based on each data set 
obtained with the ECVUE, an activation map of both ventricles was generated offline by 
animating the activation waveform on the subject-specific CT-derived epicardial surface. 
Ventricular activation times were calculated from the onset of the QRS to the maximal negative 
slope of each electrogram and combined to construct 3D epicardial isochrone maps. (Figure 1) 
Specific raw data were extracted to permit the calculation of total VaT (TVaT) and VaT10-90 which 
represent a complex engineering task from custom-developed MATLAB code (MathWorks, 
Natick, MA) previously used by the authors [6,14]. 
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Statistical analyses  
Statistical analyses were performed using PASW Statistics 21 (SPSS Inc., Chicago, IL). Changes in 
VaTs were compared using the Mann-Whitney U test, ANOVA and the Kruskal–Wallis Test. Any 
post hoc comparisons were performed using Tukey’s HSD. Correlations were assessed by the 
Pearson correlation test. P values less than 0.05 were deemed statistically significant.  
 
 
Results 
The study population consisted of 19 subjects. (Table 1). Mean age was 68±13 years, 79% were 
ischemic and 74% had LBBB. The baseline TVaT for the entire group was 145.5ms, and VaT10-90 
was 83.4ms. (Table 2) When comparing ischemic and non-ischemic patients, there was no 
significant difference in the baseline value of TVaT (146±23 vs 144±27, ms) or VaT10-90 (84±18 
vs 82±28, ms). 
Optimization of the pacing vector 
TVaT and VaT10-90 for each pacing vector are shown in Table 3. Vectors with a high threshold and 
PNS were excluded. Across all patients, there was no significant difference in the average TVaT 
or VaT10-90 based on the vectors used in either true bipolar or extended bipolar configurations, 
suggesting that changing the site of stimulation from the quadripolar lead did not significantly 
affect ventricular activation time across all patients and that no particular vector was more 
effective in all patients. There were significant changes in activation times in individual patients 
depending on the LV vector. For the entire group, the optimal pacing vector (defined as the 
vector that produced the shortest activation time for a particular patient) significantly 
decreased from baseline TVaT and VaT10-90, by a mean of 16±29ms and 31±23ms, respectively. 
TVaT and VaT10-90 were reduced by 19±22 and 33±17ms in ischaemic subjects and by 10±40 and 
28±32ms in non-ischemic patients, respectively. (Figure 2) No single pacing vector consistently 
produced the shortest ventricular activation time or resulted in the most substantial reduction 
of ventricular activation times in comparison to the baseline values across all, ischemic or non-
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ischemic patients. (Table 3) Figure 3 shows TVaT and VaT10-90 for the individual vectors tested 
for ischaemic and non-ischaemic cases.  
 
 
Optimal vs worst vector programming 
 
There were marked differences between the most and least synchronous pacing vectors for the 
whole group (42±23ms for TVaT and 31±16ms for VaT10-90) (Table 4) this represented a 28% 
difference in TVaT for the optimal versus the worst configuration and 37% for VaT10-90. These 
differences were apparent in both ischemic and non-ischemic patients (43 and 28ms for TVaT 
and VaT10-90 in ischaemic, and 41 and 36ms in non-ischaemic). Figure 4 shows the difference 
between the most and least synchronous pacing vectors for TVaT and VaT10-90 in each patient. 
The optimal TVaT and VaT10-90 timings were achieved in 47% and 63% of patients, respectively, 
when pacing from LV vectors that are only present in a quadripolar lead and not from the 
standard bipolar and extended bipolar vectors that would be available in a bipolar lead. (D1_M2 
and D1_RV).  
 
 
 
 
 
 
Discussion 
 
We studied the effects of different LV stimulation configurations via a quadripolar LV lead on 
ventricular activation times using non-invasive ECG mapping.  
The findings of the current study were: 
1) CRT delivered via a quadripolar lead resulted in a significant shortening of activation 
times compared to baseline, consistent with efficient resynchronisation.  
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2) No single vector was associated with more rapid ventricular activation in all subjects. 
However, there were significant changes in ventricular activation times depending on 
the vector selected.  
3) There was a marked reduction in ventricular activation times between the optimal and 
worst vectors in both ischemic and non-ischemic patients. 
4) Optimal resynchronisation was commonly achieved using non-conventional bipolar and 
extended bipolar configurations only available by using a quadripolar lead. 
 
Our findings suggest that use of the optimal stimulation electrode/vector is essential to achieve 
optimal resynchronisation. Unfortunately, this would appear to require individual tailoring of 
the vector for each patient, since no single vector was most effective for shortening of 
ventricular activation throughout the entire group. Our findings suggest that the difference 
between programming an optimal and a non-optimal configuration may significantly affect the 
degree of resynchronisation that can be effected by a quadripolar lead, with a 28% difference in 
ventricular resynchronisation assessed by TVaT compared to baseline depending on the vector 
used and an even greater difference of 37% for VaT10-90 a metric which reflects the bulk of 
ventricular activation  
 
 
 
Comparison with previous studies 
 
The findings of the present study are consistent with the results of recent studies[4,15] showing 
that more effective CRT could be achieved with quadripolar leads compared to bipolar leads. 
The availability of more programming options should increase the chance that a particular 
patient will achieve optimal resynchronisation. A notable finding of this study, in addition to the 
individual variation in the optimal stimulation site, is that this individual variation was seen in 
both ischaemic and non-ischaemic patients. This suggests that optimal vector selection is 
important in both non-ischemic and ischemic subjects. While this may seem intuitive in ischemic 
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patients, in whom stimulation from a particular vector in proximity to scar may result in 
ineffective CRT, the variability seen in non-ischemic patients may reflect areas of scar/slow 
conduction/diffuse fibrosis which may not be readily visualised with standard imaging 
tools.[16] In a large proportion of cases optimal resynchronization was achieved with non-
standard bipolar or extended bipolar configurations highlighting the potential benefit of the 
additional vectors on a quadripolar lead compared to bipolar leads. The number of subjects in  
whom activation times were assessed is comparable to those in previous studies.[17] Calo et al 
found pacing configurations using the most proximal poles offered better acute haemodynamic 
response. [18] In keeping with this in our non-ischaemic subjects more basal vectors produced 
shorter timings, which is consistent with the hypothesis that more basal stimulation may 
provide better resynchronisation. However, this was not the case in ischaemic individuals, 
where stimulation from more distal vectors was associated with more rapid ventricular 
activation, which may be related to the presence of scar.  
 
Clinical significance 
The use of quadripolar leads has become the standard of care, since they have been shown to be 
superior to bipolar leads. Initially, this was related to a reduction in PNS, but more recently, 
mortality benefits have been demonstrated.[4,15] The presence of additional poles makes it 
possible to program vectors to make CRT more effective. Programming of the optimal 
vector/configuration may be critical in this regard. Our findings suggest that optimisation needs 
to be tailored to the individual patient in order to achieve the optimal resynchronisation. This 
would appear to be important in ischemic as well as non-ischemic patients. Programming of 
vectors commonly used involving the distal pacing vectors was commonly found not to be 
optimal in this patient group. The data presented here are from a relatively small population at a 
single centre, and the findings will need to be validated in a larger study. If these findings are 
confirmed this may have important clinical significance and would suggest that such imaging 
techniques could be used program the optimal pacing vector in individual patients that may 
improve CRT response. 
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Limitations 
The data presented here are from a relatively small population at a single centre, and the 
findings will need to be validated in a larger study. Perhaps, a larger population study could 
show a significant difference in ventricular activation timings between vectors used in true 
bipolar or extended bipolar configurations enhancing the benefits of a quadripolar lead implant. 
Nonetheless, the sample size is similar to those in previous studies of non-invasive mapping in 
CRT. We did not systemically assess the presence or distribution of myocardial scar in our 
patients, and it is unclear whether the results regarding activation times are directly related to 
the presence and distribution of scar/slow conduction. This study did not consider lead 
placement (all leads were targeted to a lateral or postero-lateral vein) and an assessment of 
activation times from different coronary veins would be of interest but is beyond the scope of 
the current study. Short-term clinical outcomes were not assessed and, despite acute evaluation 
of activation times being markers of ventricular resynchronisation, does not necessarily give 
insight into CRT outcomes in the long term, and further studies will be required to assess 
whether the acute optimisation of activation translates into long-term benefits and a response to 
CRT.  
 
Conclusion 
Non-invasive ECM allows assessment of the effects of quadripolar programming on ventricular 
activation. Changes in quadripolar configurations appear to have a significant impact in both 
ischemic and non-ischemic patients, and thus individual tailoring may be required to give the 
best response to treatment. 
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Figure 1 – Example of 3D epicardial isochrone maps obtained for Patient 4 with the LV 
lead configurations in a DDD pacing mode using the optimal atrioventricular delay 
(AVD) and VV were identified through echo-guided optimisation. A - D1 – Distal pole of 
an LV quadripolar lead to RV; B - M2 – 2nd Middle pole of an LV quadripolar lead to RV; 
C - M3 – 3rd Middle pole of an LV quadripolar lead to RV; D - P4 – Proximal pole of an LV 
quadripolar lead to RV; RV – Proximal pole (Coil) of an RV bipolar lead 
 
Figure 2 – Differences in VaT10-90 between baseline and the optimal vector in individual 
ischaemic and non-ischaemic subjects.  
X-axes show patient identifiers. 
 
Figure 3 - VaT10-90 and TVaT values in individual ischaemic and non-ischaemic patients 
according to the LV configuration 
 
Figure 4 – Difference between the most and least synchronous pacing vectors for VaT10-90 and 
TVaT according to the LV configuration 
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Table 1 Subject Characteristics 
 value (%)  
Age (y) 68± 13 
Sex  
Male 15 (79) 
Female 4 (21) 
Aetiology  
Ischaemic 12 (63) 
Non-ischaemic 7 (37) 
QRS duration (ms)  
120 – 150 ms 5 (26) 
>150 ms 14 (74) 
QRS morphology  
LBBB 14 (74) 
Non - LBBB 5 (26) 
Atrial Status  
Atrial Fibrillation 5 (26) 
Sinus Rhythm 14 (74) 
NHYA  
II 2 (11) 
III 17 (89) 
 
LBBB, left bundle branch block; LV, left ventricle; NYHA, New York Heart Association; 
Non-LBBB, non-left bundle branch block; RV, right ventricle  
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Table 2 Baseline Ventricular Activation Times According to Aetiology 
 
Aetiology N VaT10-90 
(ms) 
TVaT  
(ms) 
Ischaemic 12 84±18 146±23 
Non-Ischaemic 7 82±28 144±27 
Total 19 83.6±21 145.5±24 
 
TVaT, total ventricular activation time; VaT10-90, delay between the 10th and 90th 
percentiles of VaT 
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Table 3. Ventricular Activation Times under Different LV Configurations with a Quadripolar LV 
Lead with regard to the Aetiology 
  Aetiology 
  Ischaemic Non-Ischaemic Total 
LV 
Configuration 
N VaT10-90  
(ms) 
TVaT 
(ms) 
N VaT10-90 
(ms) 
TVaT 
(ms) 
N VaT10-90 
(ms) 
TVaT 
(ms) 
D1_RV 12 65±27 147±37 7 66±20 138±35 19 65±24 143±34 
M2_RV 12 64±15 145±27 7 67±16 146±32 19 65±15 146±28 
M3_RV 11 63±20 142±28 7 64±14 143±32 18 63±18 142±29 
P4_RV 12 63±18 150±24 6 74±26 146±26 18 66±21 149±24 
D1_P4 12 67±15 142±28 6 67±19 143±36 18 67±16 143±30 
D1_M2 10 60±16 135±32 7 76±29 160±48 17 67±23 145±40 
M3_M2 8 75±16 149±27 6 66±18 134±26 14 71±17 143±27 
M3_P4 10 64±16 144±37 7 67±14 151±28 17 65±15 147±33 
Total 87 65±18 145±29 53 68±19 145±32 140 66±19 145±30 
  0.728*† 0.947*†  0.990*† 0.964*†  0.940*† 0.988*† 
 
D1 – Distal pole of an LV quadripolar lead; M2 – 2nd Middle pole of an LV quadripolar lead; M3 – 3rd 
Middle pole of an LV quadripolar lead; P4 – Proximal pole of an LV quadripolar lead; RV – Proximal 
pole (Coil) of an RV bipolar lead 
*ANOVA and Kruskal–Wallis Test within LV Configurations 
†All between-group comparisons were not significant (Tukey HSD). 
Only vectors with confirmed myocardial capture and the absence of PNS were used. 
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Table 4. Difference in VaT10-90 and TVaT Between the Most and Least Synchronous Pacing Vectors 
with Regard to Aetiology 
Aetiology N VaT10-90 Worst – Optimal (ms) TVaT Worst – Optimal (ms) 
Ischaemic 12 28±12 43±23 
Non-Ischaemic 7 36±21 41±25 
  0.482* 0.902* 
Total 19 31±16 42±23 
  0.456* 0.456* 
 
*Independent samples Kruskal-Wallis test 
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Highlights 
 Electrical resynchronisation by VaT10-90 reflecting the bulk of myocardial 
activation 
 Significant shortening compared to baseline via quadripolar lead 
 Reduction between optimal and worst vectors in both ischemic and non-ischemic 
 Optimal resynchronisation achieved using non-conventional bipolar 
configurations 
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